These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33047497)

  • 1. Interventions for people at ultra-high risk for psychosis: A systematic review of economic evaluations.
    Ologundudu OM; Lau T; Palaniyappan L; Ali S; Anderson KK
    Early Interv Psychiatry; 2021 Oct; 15(5):1115-1126. PubMed ID: 33047497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk stratification for treating people at ultra-high risk for psychosis: A cost-effectiveness analysis.
    Ologundudu OM; Palaniyappan L; Cipriano LE; Wijnen BFM; Anderson KK; Ali S
    Schizophr Res; 2023 Nov; 261():225-233. PubMed ID: 37804598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuated psychotic and basic symptom characteristics in adolescents with ultra-high risk criteria for psychosis, other non-psychotic psychiatric disorders and early-onset psychosis.
    Lo Cascio N; Saba R; Hauser M; Vernal DL; Al-Jadiri A; Borenstein Y; Sheridan EM; Kishimoto T; Armando M; Vicari S; Fiori Nastro P; Girardi P; Gebhardt E; Kane JM; Auther A; Carrión RE; Cornblatt BA; Schimmelmann BG; Schultze-Lutter F; Correll CU
    Eur Child Adolesc Psychiatry; 2016 Oct; 25(10):1091-102. PubMed ID: 26921232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up of a group at ultra high risk ("prodromal") for psychosis: the PACE 400 study.
    Nelson B; Yuen HP; Wood SJ; Lin A; Spiliotacopoulos D; Bruxner A; Broussard C; Simmons M; Foley DL; Brewer WJ; Francey SM; Amminger GP; Thompson A; McGorry PD; Yung AR
    JAMA Psychiatry; 2013 Aug; 70(8):793-802. PubMed ID: 23739772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural neuroimaging in psychosis: a systematic review and economic evaluation.
    Albon E; Tsourapas A; Frew E; Davenport C; Oyebode F; Bayliss S; Arvanitis T; Meads C
    Health Technol Assess; 2008 May; 12(18):iii-iv, ix-163. PubMed ID: 18462577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive Behavioural Therapy for Psychosis: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2018; 18(5):1-141. PubMed ID: 30443277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of preventing first-episode psychosis in ultra-high-risk subjects: multi-centre randomized controlled trial.
    Ising HK; Smit F; Veling W; Rietdijk J; Dragt S; Klaassen RM; Savelsberg NS; Boonstra N; Nieman DH; Linszen DH; Wunderink L; van der Gaag M
    Psychol Med; 2015 May; 45(7):1435-46. PubMed ID: 25330734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of economic evaluations of health care for people at risk of psychosis and for first-episode psychosis.
    Shields GE; Buck D; Varese F; Yung AR; Thompson A; Husain N; Broome MR; Upthegrove R; Byrne R; Davies LM
    BMC Psychiatry; 2022 Feb; 22(1):126. PubMed ID: 35177010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salivary cortisol in early psychosis: New findings and meta-analysis.
    Chaumette B; Kebir O; Mam-Lam-Fook C; Morvan Y; Bourgin J; Godsil BP; Plaze M; Gaillard R; Jay TM; Krebs MO
    Psychoneuroendocrinology; 2016 Jan; 63():262-70. PubMed ID: 26520686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early psychotic experiences: Interventions, problems and perspectives.
    Dimitrakopoulos S; Kollias C; Stefanis NC; Kontaxakis V
    Psychiatriki; 2015; 26(1):45-54. PubMed ID: 25880383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Designing and Testing of a Health-Economic Markov Model for Prevention and Treatment of Early Psychosis.
    Wijnen BFM; Thielen FW; Konings S; Feenstra T; Van Der Gaag M; Veling W; De Haan L; Ising H; Hiligsmann M; Evers SMAA; Smit F; Lokkerbol J
    Expert Rev Pharmacoecon Outcomes Res; 2020 Jun; 20(3):269-279. PubMed ID: 31195900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adolescents at ultra-high risk for psychosis with and without 22q11 deletion syndrome: a comparison of prodromal psychotic symptoms and general functioning.
    Armando M; Girardi P; Vicari S; Menghini D; Digilio MC; Pontillo M; Saba R; Mazzone L; Lin A; Klier CM; Schäfer MR; Amminger GP
    Schizophr Res; 2012 Aug; 139(1-3):151-6. PubMed ID: 22627123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychosis risk screening in different populations using the Prodromal Questionnaire: A systematic review.
    Savill M; D'Ambrosio J; Cannon TD; Loewy RL
    Early Interv Psychiatry; 2018 Feb; 12(1):3-14. PubMed ID: 28782283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
    Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
    Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detection and early treatment of subjects at high risk of clinical psychosis: Definitions and recommendations].
    Michel C; Toffel E; Schmidt SJ; Eliez S; Armando M; Solida-Tozzi A; Schultze-Lutter F; Debbané M
    Encephale; 2017 May; 43(3):292-297. PubMed ID: 28347521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical effectiveness and cost-effectiveness of low-intensity psychological interventions for the secondary prevention of relapse after depression: a systematic review.
    Rodgers M; Asaria M; Walker S; McMillan D; Lucock M; Harden M; Palmer S; Eastwood A
    Health Technol Assess; 2012 May; 16(28):1-130. PubMed ID: 22642789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The history of childhood trauma among individuals with ultra high risk for psychosis is as common as among patients with first-episode schizophrenia.
    Sahin S; Yüksel Ç; Güler J; Karadayı G; Akturan E; Göde E; Özhan AA; Üçok A
    Early Interv Psychiatry; 2013 Nov; 7(4):414-20. PubMed ID: 23343404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testing the Ultra High Risk (prodromal) criteria for the prediction of psychosis in a clinical sample of young people.
    Yung AR; Stanford C; Cosgrave E; Killackey E; Phillips L; Nelson B; McGorry PD
    Schizophr Res; 2006 May; 84(1):57-66. PubMed ID: 16630707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Ultra-High-Risk for psychosis groups: Evidence to maintain the status quo.
    McHugh MJ; McGorry PD; Yuen HP; Hickie IB; Thompson A; de Haan L; Mossaheb N; Smesny S; Lin A; Markulev C; Schloegelhofer M; Wood SJ; Nieman D; Hartmann JA; Nordentoft M; Schäfer M; Amminger GP; Yung A; Nelson B
    Schizophr Res; 2018 May; 195():543-548. PubMed ID: 29055567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.